Skip to main content
. 2021 Sep 27;34(5):280–292. doi: 10.1089/jamp.2020.1618

Table 1.

Particle Characteristics for NEXThaler DPI (BDP/FF), Ellipta DPI (FluF/Vil), and Turbohaler DPI (Bud/FF)

Devicea Active pharmaceutical ingredient Mass median aerodynamic diameter (μm) Geometric standard deviation DD (μg) Fine particle fraction (% of DD) Drug release time (second)
60 L/min flow rate
 NEXThaler DPI
100 + 6 μg
BDP 1.3 2.6 81.9 56.8 0.099
FF 1.5 1.8 5.0 58.7
 Ellipta DPI
92 + 22 μg
FluF 3.8 2.1 91.6 23.8 0.124
Vil 2.1 2.1 22.5 45.3
 Turbohaler DPI
200 + 6 μg
Bud 2.1 1.8 163.5 62.2 0.137
FF 2.1 1.9 4.6 62.8
40 L/min flow rate
 NEXThaler DPI
100 + 6 μg
BDP 1.2 2.4 81.9 59.7 0.124
FF 1.6 1.9 5.0 58.6
 Ellipta DPI
92 + 22 μg
FluF 4.1 2.1 90.7 23.7 0.131
Vil 2.2 2.3 22.1 42.3
 Turbohaler DPI
200 + 6 μg
Bud 2.8 1.8 138.4 48.1 0.167
FF 2.7 1.9 3.9 48.4
30 L/min flow rate
 NEXThaler DPI
100 + 6 μg
BDP 1.5 2.6 84.4 57.3 0.171
FF 2.3 2.0 4.9 54.6
 Turbohaler DPI
200 + 6 μg
Bud 3.0 1.9 125.8 29.5 0.407
FF 2.9 1.8 3.5 29.8
a

Doses shown are for ICS and LABA, respectively. Presented results are mean of two replicate measurements performed on a single unit for each device.

BDP, beclomethasone dipropionate; Bud, budesonide; DD, delivered dose; DPI, dry powder inhaler; FF, formoterol fumarate; FluF, fluticasone furoate; ICS, inhaled corticosteroid; LABA, long-acting beta2-agonist; Vil, vilanterol trifenatate.